BofA reiterates Buy on PTC Therapeutics stock citing Sephience launch momentum

BofA reiterates Buy on PTC Therapeutics stock citing Sephience launch momentum

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.